Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408901 · ClinicalTrials.gov registry record · NA
Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)
A NA study of Peripheral Arterial Disease, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT01408901 is a NA study of Peripheral Arterial Disease that has completed, run by Northwestern University. The registered enrollment target is 210 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01408901, a NA study of Peripheral Arterial Disease, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
The PROPEL study will test the hypothesis that GM-CSF combined with supervised treadmill exercise will significantly improve functional performance in patients with PAD more than GM-CSF alone or supervised treadmill exercise alone. In addition to identifying novel therapeutic options for patients with PAD, the current proposal is expected to identify mechanisms by which functional impairment is improved in patients with PAD.
Conditions Studied
Interventions
- BEHAVIORAL Supervised Treadmill Exercise Therapy
- OTHER Health education sessions (Control)
- DRUG granulocyte macrophage colony stimulating factor (GM-CSF)
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2011-09 |
| Est. Completion | 2017-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01408901
The ClinicalTrials.gov registry entry for NCT01408901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 3 interventions - of which Supervised Treadmill Exercise Therapy is the first listed.
NCT01408901 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01408901 about?
NCT01408901 is a clinical study titled "Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)". The PROPEL study will test the hypothesis that GM-CSF combined with supervised treadmill exercise will significantly improve functional performance in patients with PAD more than GM-CSF alone or supervised treadmill exercise alone. In addition to identifying novel therapeutic options for patients wi...
What is the current status of trial NCT01408901?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2011-09. Estimated completion is 2017-08-15.
What conditions does trial NCT01408901 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT01408901?
The interventions under investigation include: Supervised Treadmill Exercise Therapy (BEHAVIORAL), Health education sessions (Control) (OTHER), granulocyte macrophage colony stimulating factor (GM-CSF) (DRUG).
Who is sponsoring clinical trial NCT01408901?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01408901 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.